24 August 2026
Roche-Lilly pTau217 blood test cleared
On Aug. 24, 2026, Roche said the FDA cleared Elecsys Phospho-Tau (217P) Plasma for amyloid pathology assessment in people 55 and older with cognitive complaints.
The full briefing is in the app.
24 August 2026
On Aug. 24, 2026, Roche said the FDA cleared Elecsys Phospho-Tau (217P) Plasma for amyloid pathology assessment in people 55 and older with cognitive complaints.
The full briefing is in the app.